Concerning targeted approaches to block DDR1 aiming to sensitize tumor cells, Aguilera et al. have demonstrated that 7rh reduced DDR1 signaling up to 500 nM in a time-dependent manner in vitro in pancreatic cells and increased response to gemcitabine in vivo in a xenograft model [61]. The gene discussed is DDR1; the disease is neoplasm.